Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q

AbstractBackground. Within PF-EPN-A, 1q gain is a marker of poor prognosis, however, it is unclear if within PF-EPN-A additional cytogenetic events exist which

Saved in:
Bibliographic Details
Main Authors: Baroni, Lorena V. (Author) , Sundaresan, Lakshmikirupa (Author) , Heled, Ayala (Author) , Coltin, Hallie (Author) , Pajtler, Kristian Wilfried (Author) , Lin, Tong (Author) , Merchant, Thomas E. (Author) , McLendon, Roger (Author) , Faria, Claudia (Author) , Buntine, Molly (Author) , White, Christine L. (Author) , Pfister, Stefan (Author) , Gilbert, Mark R. (Author) , Armstrong, Terri S. (Author) , Bouffet, Eric (Author) , Kumar, Sachin (Author) , Taylor, Michael D. (Author) , Aldape, Kenneth D. (Author) , Ellison, David W. (Author) , Gottardo, Nicholas G. (Author) , Kool, Marcel (Author) , Korshunov, Andrey (Author) , Hansford, Jordan R. (Author) , Ramaswamy, Vijay (Author)
Format: Article (Journal)
Language:English
Published: 13 February 2021
In: Neuro-Oncology
Year: 2021, Volume: 23, Issue: 8, Pages: 1360-1370
ISSN:1523-5866
DOI:10.1093/neuonc/noab034
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/noab034
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/neuro-oncology/article/23/8/1360/6134455
Get full text
Author Notes:Lorena V. Baroni, Lakshmikirupa Sundaresan, Ayala Heled, Hallie Coltin, Kristian W. Pajtler, Tong Lin, Thomas E. Merchant, Roger McLendon, Claudia Faria, Molly Buntine, Christine L. White, Stefan M. Pfister, Mark R. Gilbert, Terri S. Armstrong, Eric Bouffet, Sachin Kumar, Michael D. Taylor, Kenneth D. Aldape, David W. Ellison, Nicholas G. Gottardo, Marcel Kool, Andrey Korshunov, Jordan R. Hansford, and Vijay Ramaswamy
Description
Summary:AbstractBackground. Within PF-EPN-A, 1q gain is a marker of poor prognosis, however, it is unclear if within PF-EPN-A additional cytogenetic events exist which
Item Description:Gesehen am 02.11.2021
Physical Description:Online Resource
ISSN:1523-5866
DOI:10.1093/neuonc/noab034